Relate
|
|
CTX; Cytoxan | |
|
A chronic disorder marked by hardening and thickening of the skin. Scleroderma can be localized or it can affect the entire body (systemic).
|
An anticancer drug that belongs to the family of drugs called alkylating agents.
|
Scleroderma as related to Cyclophosphamide
- SCOT Study | Scleroderma: Cyclophosphamide or Transplantation
SCOT (Scleroderma: Cyclophosphamide or Transplantation) is a clinical research study, designed for people with severe forms of scleroderma, that compares two investigational ...
- Scleroderma: Cyclophosphamide or Transplantation (SCOT) - Full Text ...
Scleroderma: Cyclophosphamide or Transplantation (SCOT) This study is currently recruiting participants. Verified by National Institute of Allergy and Infectious Diseases (NIAID ...
- Scleroderma Cyclophosphamide or Transplantation (SCOT) Study
September 27, 2007. Scleroderma Cyclophosphamide or Transplantation (SCOT) Study IRB Number: 26002 Institutional Review Board Hospital for Special Surgery
- SCOT Study | Information for Interested Study Participants
SCOT (Scleroderma: Cyclophosphamide or Transplantation) is a clinical research study, designed for people with severe forms of scleroderma, that compares two investigational ...
- Scleroderma: Cyclophosphamide or Transplantation (SCOT) - Full Text ...
Scleroderma: Cyclophosphamide or Transplantation (SCOT) This study is currently recruiting participants. Verified by National Institute of Allergy and Infectious Diseases (NIAID ...
- NEJM -- Cyclophosphamide for Scleroderma Lung Disease
Editorial from The New England Journal of Medicine -- Cyclophosphamide for Scleroderma Lung Disease
- High Dose Cyclophosphamide for Treatment of Scleroderma - Full Text ...
High Dose Cyclophosphamide for Treatment of Scleroderma This study is currently recruiting participants. Verified by Johns Hopkins University, July 2007
- Scleroderma - Wikipedia, the free encyclopedia
Immunol. 12 (3): 165-73. PMID 16295521 . Full text at PMC : 2275417 ^ Tashkin DP, Elashoff R, Clements PJ, et al (June 2006). " Cyclophosphamide versus placebo in scleroderma lung disease ...
- NEJM -- Cyclophosphamide in Scleroderma Lung Disease
Correspondence from The New England Journal of Medicine -- Cyclophosphamide in Scleroderma Lung Disease
- Scleroderma: Treatment - MayoClinic.com
A 2006 study of people with scleroderma-related lung disease found cyclophosphamide modestly improved lung function and quality of life. The long-term effects of cyclophosphamide ...

Not Signed In -


